# MicroPort and Yunfeng Capital to acquire LivaNova's CRM business for $190 million

MicroPort Scientific Corporation and Chinese PE firm Yunfeng Capital will acquire the cardiac rhythm management (CRM) business of LivaNova for $190 million in cash.

- Type: Acquisition
- Announced: 2018-02-20
- Where: United Kingdom
- Value: $190.0M
- Status: announced
- Products: cardiac rhythm management devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [LivaNova](https://endata.com/companies/8038.md) (target)
- [Lombard Medical](https://endata.com/companies/20848.md) (target)
- [MicroPort Scientific Corporation](https://endata.com/companies/20849.md) (acquirer)
- [Yunfeng Capital](https://endata.com/companies/30273.md) (acquirer)
- [Yunfeng Fund](https://endata.com/companies/30561.md) (acquirer)

## Sources

- [dealstreetasia.com](https://www.dealstreetasia.com/stories/microport-yunfeng-acquire-business-franchise-medical-tech-firm-livanova-93028), 2018-02-23: "Hong Kong-listed medical device manufacturer MicroPort Scientific Corporation and Chinese PE firm Yunfeng Capital will acquire the cardiac rhythm management (CRM) business of US-listed medical technology company LinaNova for $190 million in cash."
- [chinalawinsight.com](https://www.chinalawinsight.com/2018/03/articles/corporate-ma/king-wood-mallesons-advises-yunfeng-fund-and-microport-jointly-acquired-livanova-plcs-cardiac-rhythm-management-business-ranking-fifth-largest-in-the-world/), 2018-03-08: "With the completion of this acquisition, MicroPort will become one of the world’s leading suppliers of CRM equipment."
- [vascularnews.com](https://vascularnews.com/behind-microport-acquisition-lombard-medical-whats-next/), 2018-12-11: "In April 2018, Chinese medical device company MicroPort Scientific acquired UK-based Lombard Medical."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.